{"nct_id":"NCT01094288","title":"A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel Regimen","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2010-08-17","start_date_type":"ACTUAL","primary_completion_date":"2014-02-28","primary_completion_date_type":"ACTUAL","completion_date":"2017-01-04","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TAK"]}